Efrat Dotan MD presenting the results of her GIANT study of older adults with metastatic pancreatic cancer SIOG #SIOG2024

Grant R. Williams, MD, MSPH, FASCO new SIOG president sharing his vision and plans at #SIOG2024

Heartfelt congrats to Enrique Soto on his receipt of the Paul Calabresi award SIOG. So proud of you!!!

Do you have advanced non-small cell #LungCancer and are aged 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @DrSteveMartin Efrat Dotan MD Carolyn Presley, MD MHS

Academic & community cancer care complement one another. Yes, cancer care is more complex…but there are real potential harms when people choose not to receive care close to home - (financial, psychosocial, equity, caregiver burden etc) - we do not talk about that enough (and

We are pleased to welcome Efrat Dotan, MD, MTR, to Penn Medicine Lancaster General Health as executive medical director of the Ann B. Barshinger Cancer Institute. Dr. Dotan succeeds founding medical director Randall Oyer, MD, who retires from the practice of medicine after more than 40 years. Efrat Dotan MD

Great job on this, a critically important strategy that warrants more investigation Cancer and Aging Research Group (CARG) #GeriOnc SIOG #GeriOnc

my comments on this WSJ article - oncologynewscentral.com/article/commun…

Introducing new PC3I Faculty Efrat Dotan MD, Executive Medical Director at the Ann B Barshinger Cancer Institute at Penn Medicine Lancaster General Health! Her work focuses on developing novel treatment approaches for older adults w/ gastrointestinal cancers using anti-cancer therapies. pc3i.upenn.edu/people/efrat-d…

Finally published. 👇🏼👇🏼 SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers ⁦Journal of Clinical Oncology⁩ ascopubs.org/doi/10.1200/JC…

Do you have advanced non-small cell #LungCancer and are aged 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @DrSteveMartin Efrat Dotan MD Carolyn Presley, MD MHS

📣 mPDAC: from diagnosis to treatment - NEW micro learning Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis and is usually diagnosed at an advanced, incurable stage due to non-specific symptoms. 👉 Recognising symptoms & known risk factors is important

Results of Phase III BREAKWATER for BRAF V600E MT stage IV tx naive pts fulfilled primary endpoint for ORR (61% vs. 40%) and early trend for OS (add'l data to follow) defining a NEW standard of care. #colorectal #cancer ASCO #ASCOGI25 #colorectal #CancerResearch Nature Medicine

Nivolumab/ipilimumab versus nivolumab in MSI mCRC (CheckMate 8HW): a randomised, open-label, phase 3 trial 👇Get the full paper in the The Lancet doi.org/10.1016/S0140-… 👉Convincing activity with acceptable toxicity ❗️Practice-changing ESMO - Eur. Oncology

Thank you ⁦Action News on 6abc⁩ for increasing awareness of the alarming rise of young adult cancers and for highlighting our program at ⁦Fox Chase Cancer Center⁩ designed to optimize the care of this underrepresented patient population 6abc.com/post/young-adu…

Thrilled to share that our team Penn Medicine Penn Medicine Princeton Health has received the 2025 ACCC Innovator Award for Geriatric Oncology Program! accc-cancer.org/home/about/awa… Older adults deserve care tailored to their needs—and we made it real! and scalable Penn Cancer Innovation

Inspiring presentation by Heidi Klepin on her journey in geriatric oncology. Congratulations for well deserved winner of the geriatric oncology ASCO award. #ASCO2025

New standard of care for stage III, improved DFS with the addition of atezolizumab to FOLfOX. Yet, many questions remain regarding the length of therapy and possible use of immunotherapy alone. #ASCO2025

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25

Congratulations Neena and Fox Chase Cancer Center ! 👏🏽👏🏽👏🏽Namrata (Neena) Vijayvergia MD